4A7C-301 is a Nurr1 agonist with robust neuroprotective effects in vitro. 4A7C-301 significantly ameliorates neuropathological abnormalities and improves motor and olfactory dysfunctions in AAV2-mediated alpha-synuclein-overexpressing male mouse models. 4A7C-301 can be used for the research of Parkinsons disease[1].
Molecular Weight:
524.10
Purity:
99.86
Formula:
C27H38ClN9
Target:
Nuclear Hormone Receptor 4A/NR4A
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
